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variable right ventricles where EF may be more difficult to assess. These findings may
emphasize the unique ability of both BNP and MPI to assess global ventricular function in
geometrically complex hearts.
1152-202 Neurohormonal Activation in Children With Heart 
Failure Due to a Congenital Heart Defect
Dana Connolly, Sharda McGuire, Michael Artman, New York University School of 
Medicine, New York, NY
Background: Plasma norepinephrine (NE) and B-type natriuretic peptide (BNP) are use-
ful and accurate markers of heart failure severity in adults. Tumor necrosis factor-α (TNF-
α) has also been implicated in the neurohormonal response in adults with heart failure.
However, little is known about such responses in children. The purpose of this study was
to characterize neurohormonal activation due to heart failure in a representative sample
of children with congenital heart disease. Methods: Fifty-one children undergoing car-
diac surgery for a broad range of cardiac defects were studied. Previous cardiac surgery
had been performed in 45%. The study sample represented a wide age range (0 to 17
years; 5.3 ± 5.7; mean ± SD). On the day of surgery, heart failure severity was measured
using the New York University Pediatric Heart Failure Index (NYU PHFI) and systolic ven-
tricular function (left ventricular fractional shortening) was assessed using echocardio-
graphy. Fasting plasma NE, BNP and TNF-α levels were obtained under general
anesthesia before the surgical incision was made. Results: A strong correlation was
found between NE and BNP levels with heart failure severity (NYU PHFI scores) (Pear-
son correlations; NE: r = 0.41; p = 0.006; BNP: r = 0.63, p<0.001). Furthermore, ventricu-
lar function was inversely related to NYU PHFI (r = - 0.53; p< 0.001) and BNP levels = -
0.57; p = 0.002). In contrast, plasma TNF-α levels showed no correlation with either heart
failure severity, NE, BNP or ventricular function. Conclusions: Plasma TNF-α does not
reflect heart failure severity in children. In contrast, plasma NE and BNP levels are
directly related to the severity of heart failure, as indexed by NYU PHFI scores and the
degree of ventricular dysfunction. These results indicate that plasma BNP is a valid and
reliable measure of heart failure severity in infants, children and adolescents with con-
genital heart disease. Furthermore, the strong relationship between the degree of neuro-
hormonal activation (NE and BNP levels) and heart failure scores provides additional
validation of the NYU PHFI to quantify heart failure severity in the pediatric population.
1152-203 The Relationship of Age, Hemodynamics, and Severity 
of Illness With Brain Natriuretic Peptide Levels in 
Pediatric Heart Disease
Nancy Lin, Michael Landt, Kim Trinkaus, David Balzer, Henry Kort, Charles Canter, 
Washington University, St. Louis, MO
Background: Brain Natriuretic Peptide (BNP) blood levels correlate with hemodynamics
and severity of heart failure in adults. The validity of these relationships in pediatric heart
disease remain uncertain. Methods: We studied BNP levels in 216 pediatric patients
obtained prior to catheterization with a variety of cardiac lesions (2 ventricles/normal
anatomy-113, 2 ventricles left to right shunt-67, unrepaired right to left or bidirectional
shunt-28, post-operative Fontan-8). Severity of cardiac symptoms were graded on a 3
class scale with class 1= asymptomatic, 2= symptoms with activity, and 3= symptoms at
rest. 58 children were under 1 year of age, 45 between 1- 3 yr, 82 between 3-12 yr, and
31 > 13 yr. Results: Highly significant (p<0.0001), moderately strong correlations were
found with BNP levels and pulmonary capillary wedge pressure (r=0.40), Qp/Qs (r=0.39),
and mean pulmonary ventricular end-diastolic pressure (r=0.35). BNP levels rose signifi-
cantly (p<0.001) with functional class (medians: class 1=18 pg/ml, class 2=25 pg/ml,
class 3=540 pg/ml) and increasing age (p=0.026). Sex and race did not significantly cor-
relate with increases in BNP levels. Cardiac morphology did not impact on BNP level
independent of functional severity. For a given functional class, young patients tended to
have higher BNP levels, but this effect was not statistically significant. Conclusions: BNP
levels in pediatric heart disease correlate with increasing filling pressures and degree of
left to right shunting regardless of cardiac morphology. Elevated BNP levels appear to be
a marker for severe symptomatology with the potential, especially in infants and young
children, to enhance the detection of cardiac failure in pediatric heart disease.
1152-204 Exercise Capacity in Pediatric Heart Transplant 
Candidates
Bibhuti B. Das, Amy Taylor, Robert Wolfe, Anji T. Yetman, The Children's Hospital, 
Denver, CO
Background: Peak oxygen consumption (VO2) is a valuable tool in assessing adults with
congestive heart failure (CHF) being considered for cardiac transplantation (HT). A VO2
< 14 ml/kg/min, or a percent predicted VO2 <50% of normal, have been identified as
independant predictors of 1 year mortality and are used to determine timing of HT. The
feasibility of exercise testing and the role of VO2 measurement in children awaiting HT
have not been assessed. Method & Results: Cardiopulmonary stress testing using
cycle ergometry and a sensormedics metabolic cart was performed in 15 pediatric
patients listed, or being considered for HT at a mean age of 15.5 + 2.8 years and weight
of 46.4 + 10.1 kg. All patients went on to HT within a period of 5.9 + 5.3 months. The eti-
ology of CHF was ventricular dysfunction in the setting of a prior Fontan procedure in 4
and dilated cardiomyopathy in 11. A maximal stress test, as evidenced by a peak RQ
value >1.1 was obtained in 12 (80%) patients. Three patients had hemodynamic alter-
ations including desaturation <60% in 1, >3mm ST segment depression in 1 and ventric-
ular arrhythmias in 1. All resolved with cessation of exercise and there were no untoward
events. Peak VO2 was reduced at 18.6 + 5.2 ml/kg/min (42.6 + 12.8% predicted. Twelve
(86%) patients had a VO2 higher than the adult value of 14 ml/kg/min used for listing for
HT. Cardiac catheterization data from this population included a mean cardiac index of
2.6 + 0.6 L/m2, systemic ventricular end diastolic pressure of 18.0 + 6.6 mmHg, and pul-
monary vascular resistance index of 8.8 + 7.1 units*m2. Conclusion: In summary, car-
diopulmonary stress testing can be performed safely in children listed, or being
considered for, cardiac transplantation. Maximal tests can be obtained in the majority of
patients. The documented safety of this procedure may lead to greater utilization of
stress testing in this cohort of patients. Use of the adult peak VO2 value of <14 ml/kg/min
as a criterion for listing for HT is not applicable to children. Significant functional impair-
ment is noted at a much higher VO2. The adult transplant listing criterion of <50% pre-
dicted VO2 may be applicable to the pediatric population but requires further study.
1152-205 Exercise Responses in Children With Pulmonary 
Hypertension
Anji T. Yetman, Amy Taylor, Dunbar Ivy, University of Colorado Health Sciences Center, 
Denver, CO
Background: Adults with pulmonary hypertension (pHTN) have impaired aerobic capac-
ity when compred to healthy controls. Previous reports have shown that exercise testing
is a reproducible measure of disease severity and that peak oxygen consumption (VO2)
is predictive of 1 year mortality in adults with pHTN. Little is known regarding exercise
capacity in children with pHTN. Methods: We compared cardiopulmonary exercise
responses in children with pHTN (n=40) to healthy controls (CON, n=66). Maximal symp-
tom limited exercise was performed using cycle ergometry and a Sensormedics meta-
bolic system. Results: The etiology of the pHTN was primary in 15, congenital heart
disease in 17, and thromboemobolic/vascular disease in 8. Pulmonary vascular resis-
tance index (PVRI) at cardiac catheterization in the pHTN patients was 14.7 + 12.9
units*m2. No untoward events occurred during exercise testing. There were no differ-
ences in age (13.4 + 7.5 vs 13.8 + 2.9 years; p=0.7), gender (58% vs 57% male; p=NS)
or body mass index (19.1 + 3.9 vs 20.1 + 4.0 m2; p=0.2) between patients and controls.
Peak VO2 (20.9 + 7.0 vs 35.5 + 7.4 ml/kg/min; p<0.001), % predicted VO2 (47.4 + 14.2 %
vs 79.9 + 15.9% ; p<0.001), peak systolic blood pressure (141.7 + 22.3 vs 165.3 + 24.6
mmHg; p<0.001) and oxygen saturation at peak exercise (85.4% + 14.5 vs 94.5 + 3.3 %;
p<0.001) were significantly lower in pHTN vs CON. ∆ VE/∆ VCO2, a measure of ventila-
tory inefficiency, was significantly greater in pHTN than CON (46.8 + 10.9 vs 34.0 + 6.5;
p<0.001). The peak oxygen pulse, an indirect measure of stroke volume, was lower in
pHTN vs CON (5.3 + 2.3 vs 11.7 + 10.9 ml/beat; p<0.001). VO2 and % predicted VO2 in
patients with pHTN correlated with PVRI (r=-.59, p=.003 /r=-.65, p<0.001 respectively),
WHO class (r=-.58; p=.003), and ∆ VE/∆ VCO2 (r=-5.4, p<0.001/r=-.55, p<0.001 respec-
tively). Conclusion: Children with pHTN can safely undergo cardiopulmonary stress
testing. Exercise testing is a valuable tool in monitoring disease severity in children with
pHTN and may prove useful in assessing response to therapies. The degree of impair-
ment in aerobic capacity correlates well with other invasive measures of pulmonary vas-
cular disease.
1152-206 Cardiac Histopathologic Changes in Young Military 
Recruits Experiencing Sudden Death Due to Anomalous 
Coronary Origin Compared With Obstructive Coronary 
Artery Disease
Robert E. Eckart, Richard A. Krasuski, Stephen S. Reich, Paul D. Garrett, Charles L. 
Campbell, Eric A. Shry, Mark E. Peele, Brooke Army Medical Center, Fort Sam Houston, 
TX
Background: Sudden cardiac death (SCD) is a devastating event, particularly in the
young and otherwise healthy individual. The presence of an anomalous coronary artery,
though rare, is well established as a cause of SCD. Despite a postulated ischemic mech-
anism, it remains unclear what role chronic ischemia, fibrosis and myocardial cell death
plays in the fatal event.
Methods: We reviewed the clinical and autopsy records of all SCD occurring in military
recruits throughout the Department of Defense from 1977-2002.
Results: Thirty cases attributed to coronary artery lesions [10 with atherosclerotic coro-
nary artery disease (CAD) and 20 with anomalous coronary origin (ACO)] had full ana-
tomic and histological specimens available for direct comparison. Nearly all patients
examined were male (18/20 with CAD and 10/10 with ACO). Patients with CAD were
older (26.1±6.2 vs. 20.2±4.0 years, p=0.004) and weighed more (26.7±3.6 vs. 23.6±2.5
kg/m2, p=0.02). Patients with ACO were more likely to have had prodromal symptoms
(10/20 vs. 0/10, p=0.006), though there was no difference in the time of death from the
onset of physical training (36.0±20.0 vs. 28.8±12.5 days, p=NS). All SCD due to ACO
involved a left main coronary artery take-off from the right coronary sinus with a course
between the aorta and RVOT. In all cases of SCD due to CAD, obstructive disease
(>70%) of the left anterior descending coronary artery was present. Four of the patients
had multi-vessel disease. Myocardial fibrosis was seen equally in those with both CAD
and ACO (30% vs. 20%, p=0.66), but the finding of necrosis was more likely in individuals
with CAD (50% vs 15%, p=0.08). The incidence of either myocardial fibrosis or necrosis
in those CAD and ACO was 70% and 35% respectively (p=0.12).
Conclusions: Despite absence of prodromal symptoms, there was a 70% incidence of
histologic changes consistent with prior myocardial injury in SCD due to CAD. Silent
ischemia, with acute plaque rupture likely represents the causative factor behind SCD in
the young patient with CAD. Since patients with ACO frequently present antemortem with
anginal symptoms, it is imperative to identify the origin of the coronary arteries as poten-
tially causative.
